sRNAlyticsHeadShots_Peter.png

Peter B. Finn

Partner and Chair, Rubin and Rudman LLP

Peter has over 35 years of experience representing representing biotechnology and high technology companies in all aspects of corporate law including negotiating and drafting fee for service and licensing contracts, technology transfer, strategic alliances, venture capital and M&A. He has assisted in the launch of more than fifty biotechnology companies, and has lead venture capital financing for companies in all stages of development, in excess of $500M. Peter represents a wide range of clients and has established himself as a leading biotech lawyer in the Boston and Cambridge biotech cluster.

BACK TO TEAM